Johnson&Johnson seen lower in the coming weeks
There is no real change in the dominant bear trend, as prices pressure $110.00.
Stochastics and sentiment continue to weaken, highlighting further downside risks into the coming weeks.
In tandem, Healthcare is also weakening and, along with JNJ, further underperformance relative to the SP500 Index is highlighted.
Stochastics and sentiment continue to weaken, highlighting further downside risks into the coming weeks.
In tandem, Healthcare is also weakening and, along with JNJ, further underperformance relative to the SP500 Index is highlighted.